Fig. 5

In vitro immune modulation assay. A–C Mature markers on dendritic cells incubated with 4T1 cells pretreated with different PTX formulations. (a: control, b: PoxMTP NPs, c: PTX and d: PTX@PoxMTP NPs). (D and E) IDO1 expression analysis after different treatments by WB. (F and G) Kyn levels in tumor cells received different formulations. *P < 0.05, **P < 0.01, ***P < 0.001 and ^#P < 0.0001